A Randomized Controlled Trial Evaluating the Efficacy of E-Cigarette Use for Smoking Cessation in the General Population: E3 Trial Design

CJC Open

Volumn 2, Issue 3, 2020, Pages 168-175

  Hébert Losier, Andréa ^a   Filion, Kristian B ^a,b   Windle, Sarah B ^a   Eisenberg, Mark J ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; AMBULATORY CARE; ARTICLE; CANADA; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CURRENT SMOKER; DEVICE SAFETY; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MOTIVATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; POPULATION RESEARCH; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TELECONSULTATION; TOBACCO DEPENDENCE; TREATMENT DURATION;

EID: 85084826793     PISSN: None     EISSN: 2589790X     Source Type: Journal    
DOI: 10.1016/j.cjco.2020.03.006     Document Type: Article

References (24)

1. Creamer, M.R., Wang, T.W., Babb, S., et al. Tobacco product use and cessation indicators among adults—United States, 2018. MMWR Morb Mortal Wkly Rep, 68, 2019, 1013.
2. Caraballo, R.S., Shafer, P.R., Patel, D., Davis, K.C., McAfee, T.A., Quit methods used by US adult cigarette smokers, 2014–2016. Prevent Chronic Dis, 14, 2017, E32.
3. Caponnetto, P., Campagna, D., Cibella, F., et al. Efficiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PloS One, 8, 2013, e66317.
4. Hajek, P., Phillips-Waller, A., Przulj, D., et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 380 (2019), 629–637.
5. Masiero, M., Lucchiari, C., Mazzocco, K., et al. E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: preliminary results by randomized controlled trial. Nicotine Tobacco Res 21 (2018), 119–126.
6. Walker, N., Parag, V., Verbiest, M., et al. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial. Lancet Resp Med 8 (2020), 54–64.
7. Bullen, C., Howe, C., Laugesen, M., et al. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382 (2013), 1629–1637.
8. Carpenter, M.J., Heckman, B.W., Wahlquist, A.E., et al. A naturalistic, randomized pilot trial of e-cigarettes: uptake, exposure, and behavioral effects. Cancer Epidemiol Prevent Biomarkers 26 (2017), 1795–1803.
9. Halpern, S.D., Harhay, M.O., Saulsgiver, K., et al. A pragmatic trial of e-cigarettes, incentives, and drugs for smoking cessation. N Engl J Med 378 (2018), 2302–2310.
10. Lee, S.-H., Ahn, S.-H., Cheong, Y.-S., Effect of electronic cigarettes on smoking reduction and cessation in Korean male smokers: a randomized controlled study. J Am Board Family Med 32 (2019), 567–574.
11. Tseng, T.-Y., Ostroff, J.S., Campo, A., et al. A randomized trial comparing the effect of nicotine versus placebo electronic cigarettes on smoking reduction among young adult smokers. Nicotine Tobacco Res 18 (2016), 1937–1943.
12. Centers for Disease Control and Prevention. Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping, Products. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html Accessed January 27, 2020.
13. Krishnasamy, V.P., Update: characteristics of a nationwide outbreak of e-cigarette, or vaping, product use–associated lung injury—United States, August 2019–January 2020. MMWR Morb Mortal Wkly Rep 69 (2020), 90–94.
14. Chan, A.-W., Tetzlaff, J.M., Altman, D.G., et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Internal Med 158 (2013), 200–207.
15. Hummel, K., Brown, J., Willemsen, M.C., West, R., Kotz, D., External validation of the Motivation To Stop Scale (MTSS): findings from the International Tobacco Control (ITC) Netherlands Survey. Eur J Public Health 27 (2016), 129–134.
16. Heatherton, T.F., Kozlowski, L.T., Frecker, R.C., Fagerstrom, K.O., The Fagerström test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86 (1991), 1119–1127.
17. Olufade, A.O., Shaw, J.W., Foster, S.A., et al. Development of the smoking cessation quality of life questionnaire. Clinical Therapeut 21 (1999), 2113–2130.
18. Beck, A.T., Steer, R.A., Brown, G.K., Beck depression inventory-II. San Antonio 78 (1996), 490–498.
19. Glover, E.D., Nilsson, F., Å, Westin, et al. Developmental history of the Glover-Nilsson smoking behavioral questionnaire. Am J Health Behav 29 (2005), 443–455.
20. Program Training and Consultation Centre. Brief Counselling for Tobacco Use Cessation: A Guide for Health Professionals; 2012.
21. Lancaster, T., Stead, L.F., Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev, 3, 2017, CD001292.
22. Dixon, J.R., The international conference on harmonization good clinical practice guideline. Qual Assur 6 (1998), 65–74.
23. Salako, S.E., The declaration of Helsinki 2000: ethical principles and the dignity of difference. Med Law 25 (2006), 341–354.
24. Eisenberg, M.J., Filion, K.B., Yavin, D., et al. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ 179 (2008), 135–144.